Diplomat Announces 3rd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 hits record high as rate-hike worries ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Burry doubles down on Nebius short after stock surges 34% on earnings
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Home Depot CEO Ted Decker takes medical leave; two executives step in
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Diplomat Pharmacy (DPLO) PT Lowered to $18 at Mizuho Securities
November 8, 2018 10:49 AM ESTMizuho Securities analyst Ann Hynes lowered the price target on Diplomat Pharmacy (NYSE: DPLO) to $18.00 (from $23.00) while maintaining a Neutral rating.
Hynes commented, "We are updating our model and price target (now $18 from $23). Despite yesterday's sell-off driven by the disclosure of significant... More
Diplomat Pharmacy (DPLO) Misses Q3 EPS by 22c, Updates Guidance
November 6, 2018 4:24 PM ESTDiplomat Pharmacy (NYSE: DPLO) reported Q3 EPS of $0.00, $0.22 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Diplomat Pharmacy sees 2018 EPS of ($0.10)-$0.03, versus the consensus of $0.83. Diplomat... More
